Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × cabozantinib × 30 days × Clear all

Phase

Status

Recruiting 16 Active not recruiting 12 Terminated 2 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

pembrolizumab 29 Cyclophosphamide 18 Nivolumab 14 Paclitaxel 12 Cisplatin 11 Carboplatin 11 Radiotherapy 10 Gemcitabine 10 Surveys and Questionnaires 9 Standard of Care 8 Doxorubicin 8 Blood Specimen Collection 8 regorafenib 7 fludarabine 7 Oxaliplatin 7 Cetuximab 7 olaparib 6 Trastuzumab 6 Rituximab 6 Radiotherapy, Intensity-Modulated 6 Radiosurgery 6 Prednisone 6 Irinotecan 6 Ipilimumab 6 Fulvestrant 6 Fluorouracil 6 Docetaxel 6 Capecitabine 6 Androgen Antagonists 6 durvalumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03945773 2026-03-13

CaboPoint

Ipsen

Phase 2 Completed

127 enrolled 17 charts

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡